These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38521549)
21. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
22. Model Based Identification of Linezolid Exposure-toxicity Thresholds in Hospitalized Patients. Fang J; Zhang XS; Zhang CH; Zhou ZY; Han L; Wang YX; He XS; Bian XL; Lin GY; Jiao Z; Dai Y; Yu XB; Pan JY Front Pharmacol; 2021; 12():732503. PubMed ID: 34675806 [TBL] [Abstract][Full Text] [Related]
24. Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. Mutnick AH; Enne V; Jones RN Ann Pharmacother; 2003 Jun; 37(6):769-74. PubMed ID: 12773059 [TBL] [Abstract][Full Text] [Related]
25. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients. Cai X; Li R; Sheng C; Tao Y; Zhang Q; Zhang X; Li J; Shen C; Qiu X; Wang Z; Jiao Z Eur J Pharm Sci; 2020 Mar; 145():105237. PubMed ID: 32001346 [TBL] [Abstract][Full Text] [Related]
26. Corrigendum to "Molecular typing and antimicrobial resistance of group B Streptococcus clinical isolates in Saudi Arabia" [Journal of Global Antimicrobial Resistance 35 (2023) 244-251]. Alzayer M; Alkhulaifi MM; Alyami A; Aldosary M; Alageel A; Garaween G; Shibl A; Al-Hamad AM; Doumith M J Glob Antimicrob Resist; 2024 Mar; 36():493. PubMed ID: 38521550 [No Abstract] [Full Text] [Related]
27. A Review of Population Pharmacokinetic Analyses of Linezolid. Bandín-Vilar E; García-Quintanilla L; Castro-Balado A; Zarra-Ferro I; González-Barcia M; Campos-Toimil M; Mangas-Sanjuan V; Mondelo-García C; Fernández-Ferreiro A Clin Pharmacokinet; 2022 Jun; 61(6):789-817. PubMed ID: 35699914 [TBL] [Abstract][Full Text] [Related]
28. Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients. Li SC; Ye Q; Xu H; Zhang L; Wang Y Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642929 [TBL] [Abstract][Full Text] [Related]
29. A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam. Sisson TL; Jungbluth GL; Hopkins NK J Clin Pharmacol; 1999 Dec; 39(12):1277-82. PubMed ID: 10586394 [TBL] [Abstract][Full Text] [Related]
30. A Systematic Review on Antimicrobial Pharmacokinetic Differences between Asian and Non-Asian Adult Populations. Setiawan E; Cotta MO; Roberts JA; Abdul-Aziz MH Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237706 [TBL] [Abstract][Full Text] [Related]
31. The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Dadashi M; Sharifian P; Bostanshirin N; Hajikhani B; Bostanghadiri N; Khosravi-Dehaghi N; van Belkum A; Darban-Sarokhalil D Front Med (Lausanne); 2021; 8():720647. PubMed ID: 34568377 [No Abstract] [Full Text] [Related]
32. A mucoadhesive nanolipo gel containing Aegle marmelos gum to enhance transdermal effectiveness of linezolid for vaginal infection: In vitro evaluation, in vitro-ex vivo correlation, pharmacokinetic studies. Satapathy BS; Biswal B; Pattnaik S; Parida R; Sahoo RN Int J Pharm; 2023 Dec; 648():123542. PubMed ID: 37925044 [TBL] [Abstract][Full Text] [Related]
33. [A study of population pharmacokinetics of linezolid in Chinese]. Zhang L; Bai N; Liu YN; Wang R Zhonghua Jie He He Hu Xi Za Zhi; 2016 Dec; 39(12):924-928. PubMed ID: 27938541 [No Abstract] [Full Text] [Related]
34. Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional study. Shi L; Zhang Y; Duan L; Huang L; Li J; Lu J; Zhuang Z; Yuan Y; Feng Z; Sun J; Liu X; Zhou Q; Xue H; Xu J; Tang L Int J Antimicrob Agents; 2023 Aug; 62(2):106881. PubMed ID: 37301313 [TBL] [Abstract][Full Text] [Related]
35. Prolonged infusion of linezolid is associated with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles in patients with external ventricular drains. Zhao W; Kong L; Wu C; Wu X Eur J Clin Pharmacol; 2021 Jan; 77(1):79-86. PubMed ID: 32812063 [TBL] [Abstract][Full Text] [Related]
36. Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients. Minichmayr IK; Schaeftlein A; Kuti JL; Zeitlinger M; Kloft C Clin Pharmacokinet; 2017 Jun; 56(6):617-633. PubMed ID: 27753002 [TBL] [Abstract][Full Text] [Related]
37. Clinical experience with linezolid in the treatment of resistant gram-positive infections. Antony SJ; Diaz-Vasquez E; Stratton C J Natl Med Assoc; 2001 Oct; 93(10):386-91. PubMed ID: 11688919 [TBL] [Abstract][Full Text] [Related]
38. Erratum to 'Prevalence, biofilm formation, and mass spectrometric characterization of linezolid-resistant Staphylococcus capitis isolated from a tertiary hospital in China' [Journal of Global Antimicrobial Resistance 33 (2023) 155-163]. Zhou W; Niu D; Gao S; Zhong Q; Liu C; Liao X; Cao X; Zhang Z; Zhang Y; Shen H J Glob Antimicrob Resist; 2023 Dec; 35():358. PubMed ID: 38035931 [No Abstract] [Full Text] [Related]
39. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Smith PF; Birmingham MC; Noskin GA; Meagher AK; Forrest A; Rayner CR; Schentag JJ Ann Oncol; 2003 May; 14(5):795-801. PubMed ID: 12702536 [TBL] [Abstract][Full Text] [Related]
40. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review. Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]